Sign in

Coronary artery disease

Current status: Treatable, not yet curable

A long-term heart condition in which fatty deposits narrow the arteries that feed the heart. It can cause chest pain and breathlessness during activity, but some people have no signs until a heart attack. It cannot be cured, but lifestyle changes, medicines and procedures can ease the symptoms and lower the risk of a heart attack. The risk rises with age, and men tend to get it earlier than women.

Read more about coronary artery disease
Where research stands todayUpdated 17 Nov 2026

Trial-stage treatments and research studies you can joinOpen trials for referral

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsBelgium, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 3Taking people
    EA-230 compared with placebo during heart bypass surgery in coronary artery disease

    Tests EA-230 against placebo in adults having coronary artery bypass surgery.

    Ghent, BelgiumAge 18+
  2. Trial-stage treatmentTaking people
    Tests cold therapy on risky heart artery plaque in adults with coronary artery disease

    Tests cold therapy inside heart arteries in adults with risky plaque.

    Aalst, BelgiumAge 18+
  3. Trial-stage treatmentPhase 4Taking people
    Testing flecainide against standard drugs for atrial fibrillation with heart artery disease

    Tests flecainide against sotalol or amiodarone in adults with atrial fibrillation and stable heart disease.

    Aalst, BelgiumAlso Bonheiden, Edegem, Genk, Herentals, Ieper, Kortrijk, Leuven, Roeselare, …Age 18+
  4. Trial-stage treatmentPhase 3Taking people
    Testing Low-Dose Colchicine for People With Peripheral Artery Disease

    Tests a low dose of colchicine, an anti-inflammatory pill, in adults with narrowed leg arteries.

    Leuven, BelgiumAge 18+
  5. Trial-stage treatmentPhase 2/3Taking people
    Tests clazakizumab in adults with kidney failure on dialysis

    Tests clazakizumab against placebo in dialysis patients with heart disease or diabetes and inflammation.

    Aalst, BelgiumAlso Bonheiden, Charleroi, Ghent, La Louvière, Leuven, Liège, Roeselare, Sint-NiklaasAge 18+
  6. Trial-stage treatmentPhase 1/2Taking people
    Tests invobenitug in adults with cardiogenic shock and raised DPP3 levels

    Tests invobenitug against placebo in adults with life-threatening cardiogenic shock.

    Aalst, BelgiumAge 18 to 80
  7. Trial-stage treatment
    Tests a new bypass graft device during heart bypass surgery

    Tests a new bypass graft in adults with blocked heart arteries needing surgery.

    Leuven, BelgiumAge 18+
  8. Trial-stage treatmentPhase 4Taking people
    Shorter blood-thinner course after heart attack with ST-elevation

    Tests a shorter prasugrel blood-thinner course in people with ST-elevation heart attack.

    Bonheiden, BelgiumAlso Bruges, Genk, Leuven, Roeselare
  9. Trial-stage treatmentSoon in Belgium
    Tests a scoring balloon for calcified heart artery narrowings before stenting

    Tests the Naviscore scoring balloon to prepare calcified heart artery narrowings before stent placement.

    Bonheiden, BelgiumAlso Brussels, Libramont, Liège, Lodelinsart, MonsAge 18+
  10. Trial-stage treatmentTaking people
    Tests whether a defibrillator device is needed after a heart attack

    Tests a defibrillator device against medicines alone in adults with weak hearts after heart attack.

    Aalst, BelgiumAlso Bruges, Liège, YvoirAge 18+
  11. Trial-stage treatmentTaking people
    Heart artery imaging on a routine CT scan after surviving cardiac arrest

    Tests whether a CT scan can show heart artery problems in cardiac arrest survivors.

    Brussels, BelgiumAge 18+
  12. Trial-stage treatmentPhase 4Taking people
    Tests metoprolol against placebo for blood flow in the heart's small vessels

    Tests metoprolol against a placebo in adults with angina and no blocked coronary arteries.

    Aalst, BelgiumAge 18+
  13. Trial-stage treatmentSoon in Belgium
    Tests a surgical glue to seal stitch lines in heart and blood vessel repair

    Tests a surgical glue to seal stitches in adults having heart or vessel repair.

    Hasselt, BelgiumAge 18+
  14. Trial-stage treatmentPhase 3Taking people
    Tests colchicine after stent procedures in people with coronary artery disease

    Tests low-dose colchicine tablets against placebo in adults with coronary artery disease after PCI.

    Aalst, BelgiumAlso Antwerp, Bonheiden, Charleroi, Edegem, Genk, Hasselt, Jette, Kortrijk, …Age 45+
  15. Trial-stage treatmentPhase 4Taking people
    Tests short blood-thinner treatment after heart stenting in people with atrial fibrillation

    Tests one month of two antiplatelet drugs without anticoagulant in heart patients with atrial fibrillation.

    Aalst, BelgiumAlso Bonheiden, Edegem, Genk, Ieper, Jette, Kortrijk, Leuven, Liège, …Age 18+
  16. Trial-stage treatment
    Imaging-guided stent procedures compared with angiography-guided ones in acute coronary syndrome

    Compares imaging-guided and angiography-guided stenting in adults with acute coronary syndrome.

    Genk, BelgiumAlso Haine-Saint-Paul, Hasselt, LeuvenAge 18+
  17. Trial-stage treatmentTaking people
    Comparing CT scan and ultrasound guidance for stenting calcified heart arteries

    Compares two imaging methods to guide stent placement in adults with calcified coronary arteries.

    Aalst, BelgiumAge 18 to 85
  18. Trial-stage treatmentSoon in Belgium
    Comparing heart bypass surgery approaches in adults with coronary artery disease

    Tests MIDCAB and CABG procedures in adults with coronary artery disease needing revascularization.

    Leuven, BelgiumAge 18+
  19. Research studyTaking people
    Tracks safety and effectiveness of Medtronic products on the market

    Follows people treated with Medtronic devices for heart rhythm, brain, bladder and digestive conditions.

    Aalst, BelgiumAlso Bruges, Brussels, Edegem, Genk, Ghent, Leuven, Liège, Roeselare, …
  20. Research studyTaking people
    Registry tracking safety of Abbott heart and vessel devices in patients

    Collects data on Abbott stents and catheters used in adults with heart or vessel disease.

    Aalst, BelgiumAlso DendermondeAge 18+

Trials that have ended are not listed here, because nobody can join them. Stopped and finished Coronary artery disease trials (research view)

Take part in research

14 official research programmes take people with this disease. In a biobank or a registry you give a blood or tissue sample, or your health data, for many research teams to use.

See the research programmes

Search the publications

The results open on the publications page in a new tab, so this page stays as it is.

Lists with this disease filtered

Where treatment stands

There is no cure for coronary artery disease, but treatment can help manage the symptoms and lower the chance of problems such as heart attacks.

Approved: 71

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 31

Being tested in people. Many treatments at this stage are never approved.

Animal testing stage: 5

Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.

Words used here

Placebo: a dummy treatment without the medicine, used for comparison.

Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.

Where this comes from

The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.

A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.

The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.

Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 46 other open phase 2 trials are not listed.

Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for coronary artery disease. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.

Not medical advice. Talk to your doctor before you change any treatment.

The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. EU approvals newer than that data come from the European Commission’s Union Register, checked on 17 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.

Support organisations

Patient organisations and helplines in Belgium, for you and your family.

Coronary artery disease organisations in Belgium

  • Ligue Cardiologique Belge / Belgische Cardiologische Liga

    Prevention and information on heart and vascular disease, cardiac rehabilitation resources, patient clubs and cardiac-arrest response training.

General support in Belgium

  • Centre de Prévention du Suicide

    Francophone Belgian centre offering a free 24/7 suicide prevention listening line (0800 32 123) and support at every stage of suicidal crisis.

  • Zelfmoordlijn 1813

    Anonymous, free suicide prevention line for Dutch-speaking Belgium (phone 1813 and chat), run by the Flemish Expertise Centre for Suicide Prevention.

  • Federale Ombudsdienst Rechten van de patiënt

    Federal mediation service (FPS Public Health) handling complaints about patient rights in care outside hospitals, e.g. GPs, dentists, home nurses.

International organisations

Patient organisation umbrella bodies

Frontlight Community

Coronary artery disease community in Belgium

People living with coronary artery disease and those close to them share what they went through. Posts are not medical advice: ask your doctor about your own treatment.

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

75 medicines are approved for coronary artery disease in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Approvals not in this list yet

Found for coronary artery disease in the regulators' official registers; the list below does not show these approvals yet. We read these registers every day.

  • REPATHAevolocumab

    ApprovedNew use approved in the US by the FDA on 9 Oct 2026; the FDA label names this disease.

    Approved for: To reduce the risk of major adverse cardiovascular (CV) events (CV death, myocardial infarction, stroke, unstable angina requiring hospitalization, coronary revascularization, or any ischemia-driven arterial revascularization) in adults at increased risk for these events.

    Label (FDA, on DailyMed) ›
  • KERENDIAfinerenone

    ApprovedNew use approved in the US by the FDA on 16 Sept 2026; the FDA label names this disease.

    Approved for: Kerendia is indicated to: reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with Type 2 diabetes mellitus (T2DM) …

    Label (FDA, on DailyMed) ›
  • WEGOVYsemaglutide

    ApprovedNew use approved in the US by the FDA on 19 Mar 2026; the FDA label names this disease.

    Approved for: to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight.

    Label (FDA, on DailyMed) ›

Checked on 18 Nov 2026 in the official lists of the US (FDA), the EU (European Commission and EMA) and Switzerland (Swissmedic), which we read every day. The lists of Japan (PMDA, approvals since April 2004), France (ANSM, medicines approved in France only) and Taiwan (TFDA) were checked on 11 Nov 2026. For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 24 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

About coronary artery disease

Sources: NHS, MedlinePlus

A long-term heart condition in which fatty deposits narrow the arteries that feed the heart. It can cause chest pain and breathlessness during activity, but some people have no signs until a heart attack. It cannot be cured, but lifestyle changes, medicines and procedures can ease the symptoms and lower the risk of a heart attack. The risk rises with age, and men tend to get it earlier than women.

What is it?

The coronary arteries carry blood and oxygen to the heart muscle. Over the years, fatty deposits containing cholesterol build up inside their walls (atherosclerosis). The arteries narrow, so the heart gets less blood than it needs, and a blockage can cause a heart attack. In some people, the heart's tiny blood vessels are damaged instead; this type is more common in women.

It is the most common type of heart disease in the United States and a leading cause of death for both men and women. The risk rises with age, and men tend to get it earlier. Smoking, high blood pressure, high cholesterol, diabetes, obesity and too little activity raise the risk. It runs in families: the risk is higher if a parent, brother or sister had heart disease before 50.

The first signs

Some people have no signs, and only find out when they have a heart attack. Signs may start or get worse when you are active or under stress, and may go away with rest.

  • chest pain, pressure or tightness (angina);
  • pain that spreads to the neck, jaw, shoulders or arms;
  • shortness of breath;
  • unusual tiredness, feeling faint or feeling sick.

Chest pain that does not go away, or that comes on at rest, may be a heart attack: call the emergency number straight away.

How doctors find out

Your doctor asks about your symptoms, your family and your lifestyle, checks your blood pressure, and does blood tests for cholesterol and sugar. A risk score can estimate your chance of a heart attack or stroke in the next 10 years. Tests that can confirm it include an ECG, an echocardiogram, a chest X-ray, and a coronary angiogram, which is an X-ray that checks the blood vessels.

Current treatment

Treatment combines lifestyle changes with medicines such as blood thinners, statins and blood pressure medicines, and some people also need angioplasty with a stent or bypass surgery.

Will it get worse?

The symptoms can get worse over time as more fatty deposits build up. Over time it can lead to angina, a heart attack, heart failure or an irregular heartbeat. A healthy lifestyle may slow the disease down, and treatment can help reduce the chances of problems such as a heart attack.

Medicines: what helps, and what to watch for

Many different medicines are used to treat heart disease. Blood thinners such as low-dose aspirin or clopidogrel stop clots forming and lower the risk of a heart attack. Statins lower cholesterol. Beta blockers slow the heartbeat and help with angina. Nitrates widen the blood vessels and ease chest pain. Other medicines lower blood pressure.

Good to know:

  • nitrates can cause mild headaches, dizziness and flushed skin;
  • ACE inhibitors, such as ramipril, can cause a dry cough and dizziness, and you need regular blood tests to check your kidneys;
  • calcium channel blockers can cause headaches and a flushed face, which are usually mild and short-lived.

Exercise and therapy help too

  • cardiac rehabilitation after a heart attack: often weekly sessions that last 6 to 12 weeks, in a group, online or at home, with suitable exercise, advice on taking your medicines, stress management and support for anxiety and low mood;
  • people who go to cardiac rehabilitation are less likely to have another heart attack or go into hospital;
  • be active, eat a healthy, balanced diet and keep a healthy weight;

Procedures and surgery, for some people

In a coronary angioplasty, a small balloon pushes the fatty deposits outwards to widen a narrowed artery, and a small metal tube (stent) is usually left in to keep it open. It can be planned, or done urgently during a heart attack. In bypass surgery, a blood vessel is attached so that blood can flow around the narrowed or blocked part. Occasionally a heart transplant may be needed, when the heart is severely damaged and medicines do not work, or when the heart cannot pump enough blood.

Is there a cure?

No. Coronary heart disease cannot be cured, but treatment eases the symptoms and lowers the chance of a heart attack.

See the 1,540 trials you can join